GlassScriptPhysician profile
Emmanuelle D Williams
NPI 1245341585
$211,586.21
in general payments reported to CMS, 2019-2025
7 companies · $32K in 2025
The $32K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $27K · 2021: $15K · 2022: $22K · 2023: $11K · 2024: $61K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Travel and Lodging: $9,558 · Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,750.00 |
| Travel and Lodging | $9,558.25 |
| Food and Beverage | $3,093.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134,231.95 | 2019-2025 | Rinvoq, Skyrizi |
| Pfizer INC. | $76,680.13 | 2019-2025 | |
| Janssen Biotech, INC. | $369.73 | 2024-2025 | Tremfya, Stelara |
| Celgene Corporation | $178.67 | 2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.96 | 2024-2025 | Xifaxan |
| Ipsen Biopharmaceuticals, INC | $14.77 | 2025 | Iqirvo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuelle Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.